Envoy Medical, Inc.
COCH
$1.38
$0.010.73%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -17.65% | 15.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.65% | 15.25% | |||
| Cost of Revenue | -23.67% | 60.13% | |||
| Gross Profit | 25.99% | -88.30% | |||
| SG&A Expenses | -0.29% | -14.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.07% | -0.59% | |||
| Operating Income | -2.35% | 0.78% | |||
| Income Before Tax | -51.00% | 37.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -51.00% | 37.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -51.00% | 37.05% | |||
| EBIT | -2.35% | 0.78% | |||
| EBITDA | -2.22% | 0.95% | |||
| EPS Basic | -38.08% | 30.42% | |||
| Normalized Basic EPS | -50.83% | 37.02% | |||
| EPS Diluted | -38.08% | 30.42% | |||
| Normalized Diluted EPS | -50.83% | 37.02% | |||
| Average Basic Shares Outstanding | 0.08% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
